Free Trial

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Tpg Gp A LLC

UnitedHealth Group logo with Medical background

Tpg Gp A LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 53.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 141,762 shares of the healthcare conglomerate's stock after selling 160,011 shares during the quarter. UnitedHealth Group accounts for 1.2% of Tpg Gp A LLC's holdings, making the stock its 17th biggest position. Tpg Gp A LLC's holdings in UnitedHealth Group were worth $71,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $6,375,744,000. Raymond James Financial Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at $1,914,740,000. Amundi increased its holdings in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC increased its holdings in UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after buying an additional 1,886,186 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on UNH shares. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Mizuho dropped their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday. Finally, Truist Financial dropped their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. Six investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $486.00.

Check Out Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UNH opened at $291.24 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm's 50-day moving average price is $470.82 and its 200 day moving average price is $513.25. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a market capitalization of $264.20 billion, a PE ratio of 18.79, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period last year, the firm earned $6.91 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines